HIV-Positive Women Taking Lifelong Antiretroviral Therapy Report Better Adherence Than Women Taking Short-Course Prophylaxis During and After Pregnancy Under PMTCT Program Option A in Lusaka, Zambia

Authors

  • Karen M. Hampanda Department of Community and Behavioral Health, University of Colorado School of Public Health, Aurora, CO 80045, USA
  • Lisa L. Abuogi Department of Pediatrics, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO 80045, USA
  • Yusuf Ahmed Department of Obstetrics and Gynecology, University Teaching Hospital, Lusaka, Zambia

DOI:

https://doi.org/10.21106/ijma.164

Keywords:

  • HIV-positive Women,
  • Prevention of Mother-to-Child Transmission,
  • Antiretroviral Therapy,
  • Adherence,
  • Zambia,
  • Option A,
  • PMTCT,
  • ART

Abstract

Background and Objectives:

HIV-positive women’s adherence to antiretrovirals is critical for prevention of mother-to-child transmission. We aimed to establish if mothers taking triple lifelong antiretroviral therapy report higher adherence compared to mothers taking short-course prophylaxis under Option A in Lusaka, Zambia.

Methods:

In this clinic-based cross-sectional study, we interviewed 320 HIV-positive mothers at a large public health facility in Lusaka in 2014. Participants reported adherence using a visual analog scale. Multiple logistic regression models were used to determine the adjusted odds of adherence by mother’s prescribed regimen.

Results:

Women taking lifelong triple antiretroviral therapy report higher adjusted odds of adherence during pregnancy, postpartum, and to giving the infant prophylaxis compared to women to women taking short-course prophylaxis.

Discussion:

Women on lifelong therapy may have better adherence compared to women on short course prophylaxis because they knew their positive status for longer or were symptomatic with HIV-related disease. The lifelong therapy regimen may be easier for women to follow, particularly because they are required to give the infant prophylaxis for a shorter duration of time.

Conclusions and Global Health Implications:

Our results indicate that lifelong triple antiretroviral therapy has the potential to promote better drug adherence during and after pregnancy among women living with HIV in sub-Saharan Africa, compared to short-course antiretroviral regimens.

Downloads

Download data is not yet available.

Similar Articles

<< < 2 3 4 5 6 7 8 9 10 11 > >> 

You may also start an advanced similarity search for this article.

Downloads

Abstract Views: 2443
PDF Views/Downloads: 346
HTML Views/Downloads: 105

Published

2017-03-03
Dimensions Citation count:

How to Cite

M. Hampanda, K., L. Abuogi, L., & Ahmed, Y. (2017). HIV-Positive Women Taking Lifelong Antiretroviral Therapy Report Better Adherence Than Women Taking Short-Course Prophylaxis During and After Pregnancy Under PMTCT Program Option A in Lusaka, Zambia. International Journal of Maternal and Child Health and AIDS, 6(1), 27–35. https://doi.org/10.21106/ijma.164

License


Copyright © 2017 Karen M. Hampanda, Lisa L. Abuogi, Yusuf Ahmed. Published by Global Health and Education Projects, Inc., USA.

Creative Commons License

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License , which permits others to remix, transform, and build upon the work non-commercially, provided the original author is credited and the new creations are licensed under the same terms.